6-Mercaptopurine (6-MP) has achieved a special place in biomedicine, owing to its activity in cancer chemotherapy 21 . It is one of the oldest antineoplastic drug currently in use and as there is a good correlation between the drug's coordination chemistry (it contains sulphur and nitrogen donor sites with potential for binding at N-1, N-3, N-7 and N-9) and its chemotherapeutic activity, it has attracted much attention [22] [23] [24] . The activity of 6-MP on tumour cells is believed to be due to its ability to convert these into the corresponding ribosides. In order to suppress the undesirable side effects associated with anti-tumour drugs, metal-drug complexes are currently used as slow release prodrugs of 6-MP. The latter employ coordinated components of certain transition metals like platinum and palladium 25 . A number of detection methods have been suggested for the identification of 6-MP, which include potentiometric titration for tablet assay 26 , amperometric detection at a phthalocyanine-modified electrode 27 and spectrophotometry 28 . Whilst Zima et al. 29 reported the determination of 6-MP using tast polarography and differential pulse polarography at the dropping mercury electrode (DME), Basina et al. studied the electrochemical behaviour of 6-MP using catalytic cathodic stripping voltammetry 30 and found that 6-MP-modified mercury electrodes act as promoters for the redox exchange of Cytochrome C.
In the present work, gold nanoparticles have been used as probes for the detection of the anticancer drug 6-MP and evidence for their complexation has been obtained using UV-Visible spectroscopy, cyclic voltammetry, transmission electron microscopy (TEM), and fluorescent spectroscopy.
Furthermore, the efficacy of the complexes of 6-MP and colloidal gold is examined with biological assays in order to evaluate their antibacterial and antifungal activities.
Experimental

Apparatus
Samples were characterized by ultraviolet (U.V.)-visible spectroscopy (Perkin-Elmer Lambda 25).
The path length was 1 cm and matched 1 x 1 cm 2 cuvettes were used. Transmission electron microscopy (TEM) was undertaken employing a Tec NIE 10 instrument with an accelerating voltage of 120 kV; samples was prepared by mixing aqueous solution of MP (5mM) and gold solution (1mM). Fourier transform infrared (FTIR) spectroscopy was performed using a PE IR SPECTRUM ASCII PEDS 1.60 spectrometer and samples were presented as KBr pellets. Spectra were acquired at room temperature at a resolution of 4 cm -1 . Optical emission spectroscopy was carried out using Fluoromax-2, Gram 386 spectrometer. Cyclic voltammetric studies was performed using an Autolab PG Stat 12 electrochemical analyzer in a three electrode cell, using platinum wire as the counter electrode and a 50 mM KCl calomel reference electrode. The scans were initiated at -0.4 V and all electrochemical measurements were performed in a static nitrogen atmosphere. The working electrode used in this work was indium-tin-oxide (ITO) coated with colloidal gold and this was prepared in the following manner. The ITO slides were cleaned thoroughly by ultrasonication in water, followed by acetone. The cleaned glass slides were 
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Materials
HAuCl 4 .3H 2 O (98 %) and trisodium citrate (99 %, AR) were purchased from CDH and Analytical Rasayan respectively. 6 -Mercaptopurine (6-MP) was synthesized according to a modified, previously reported procedure 32, 33 and the purity of the sample ascertained by comparing it with the commercial sample obtained from Aldrich. The reaction scheme is given below (Scheme.2)
Insert Scheme 2
Synthesis of 6-chloropurine
To phosphoryl chloride (200 cm 3 , 2.2 mol.) was added drop wise water (20 cm 3 ) and, after all the water had been added, the mixture was boiled for 1.5 hours to dispel the hydrogen chloride. The mixture was subsequently cooled and the top layer was used for the chlorination of hypoxanthine to form 6-dichloropurine. A mixture of hypoxanthine (8 g) and pyrophosphoryl chloride (64 cm 3 ) was heated in a sealed glass tube at 165 ºC for 19 hours. After cooling, the brown solution was decanted from the solid residue in the tube and the volatile material was removed under reduced pressure. The syrupy residue was poured on to crushed ice (200 g), a small amount of tan precipitate removed and the filtrate was repeatedly extracted with portions of diethyl ether (6 x 350 cm 3 ). The ethereal solution was allowed to stand over anhydrous potassium carbonate for one hour and then over calcium sulphate overnight. On evaporation of diethyl ether, the crude product (4.3 g., 43 %), m.p. 175-177 ºC, was obtained. A small portion was recrystallized from boiling water (150 cm 3 ) and was allowed to stand at 0 ºC for 1.5 hours and then filtered through a sintered glass funnel.
Preparation of 6-mercaptopurine (6-MP)
A suspension of 6-chloropurine (0.98 g, 6.3 mmol.) and an equimolar quantity of thiourea in absolute ethanol (14 cm 3 ) was heated to reflux; the solids dissolved and soon a yellow crystalline product precipitated. After refluxing for one hour, the mixture was chilled and crude 6-MP (0.64 g) was collected, the product was dried over P 2 O 5 in vacuo at 100°C.
Preparation of citrate capped gold nanoparticles
HAuCl 4 .6H 2 O (1 mM, 500 cm 3 ) was heated and to the boiling solution was added trisodium citrate (38.8 mM, 50 cm 3 ) as one portion. After the addition, the previously yellow solution of gold chloride turned wine red in colour and gave a characteristic absorbance at 518 nm in the U.VVisible spectrum. From the TEM measurements, the average diameter of the gold nanoparticles was found to be in the range 17-18 nm.
Preparation of 6-mercaptopurine (6-MP) coated gold nanoparticles
Citrate-stabilized gold nanoparticles (1mM, 50 cm 3 ) were mixed with 6-MP (5 mM) in 2-propanol (25 cm 3 ) and stirred effectively for 5 hours until the wine red colour became blue. The 6-MP coated gold nanoparticles were obtained after centrifugation.
Details of Microbial Assay
Antibacterial and antifungal activities were studied using a disk diffusion method, wherein a suspension of both gramme positive and gramme negative organisms were added to sterile nutrient agar at 45 ºC and the mixture was solidified on a Petri dish. Disks made from filter paper dipped in 6-MP and 6-MP-gold were placed on agar plates and the plates were left for one hour at 25 ºC to allow a period of pre-incubation diffusion in order to minimize the effects of variation in time between the applications of different solutions. The plates were again incubated, this time at 37 ºC for 24 hours, and observed for antibacterial activity by determining the diameters of the zones of inhibition for each of the samples.
Results and Discussion
The plasmon band observed for the wine red colloidal gold at 518 nm in the U.V-Visible spectrum is characteristic of gold nanoparticles. Pure drug shows a maxima at 321 nm The addition of 6-MP to colloidal gold results in a reduction in the intensity of this absorption band at 518 nm and 321 nm corresponding to Au(0) and drug moiety and is accompanied by the emergence of an additional peak at 670 nm ( Figure 1 ).
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The latter can be verified by a colour change from purple to blue with the addition of drug to colloidal gold. The time dependent UV-Visible spectra were obtained after mixing (0.5 mM) 6-MP with gold nanoparticles at timed interval of 30 minutes (curves a-d); curve (e) was obtained after 5 hours. The appearance of a new peak is due to the aggregation of gold nanoparticles and the replacement of citrate by 6-MP leading to the formation of gold-drug complex.
These observations are in agreement with the data obtained using FT-IR spectroscopy. 6-MP exists as tautomer form in the solid state as C=S group and the IR spectrum of free (uncomplexed) 6-MP ( Figure 2 ) displays absorption bands at 1275 cm -1 due the presence of the C=S group.
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This peak was absent in the spectrum of the adsorbed form ( Figure 3 ) apparently confirming the existence of complex formation of the 6-MP through the sulphur atom.
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Fluorescence studies were also undertaken to ascertain the binding of the drug moiety with the gold nanoparticles. Thus, free 6-MP has a broad emission centred at ca. 380 nm when excited at a wavelength of 320 nm. The non-fluorescent gold nanoparticles are transformed into a markedly fluorescent species when added to 6-MP, the intensity of fluorescence being decreased when colloidal gold is added to the drug (Figure 4 ).
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Insert Figure 5 The fluorescence spectrum of 6-MP was studied with different concentrations of gold nanoparticles ( Figure 6 ).
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With a gradual increase in concentration of Au(0), (Figure 6b 
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The electrochemical evaluation of 6-MP capped gold nanoparticles is also shown in Figure 7b .
Peak 1 shows the cv response for the ITO electrode (modified with gold nanoparticles) in 1 mM K 4 Fe(CN) 6 at a scan rate of 10 mv/s. After the exposure of gold electrode in the 6-MP solution, a reduction in the peak current is observed due to the binding of 6-MP with the nanoparticles and more pronounced changes in the electrochemical profile of the gold electrode occur as the 6-MP concentration increases (Figure 7b ). In fact, the onset of gold oxide formation is heralded by the change to a positive potential, indicating that the 6-MP molecule has been spontaneously adsorbed on the gold surface. However at more positive potentials, a large anodic current was obtained, which should correspond to the oxidative desorption of the previously adsorbed molecule 35 , and a reduction peak was absent when the gold electrode surface was completely adsorbed by 6-MP. substrates indicates that the current is primarily controlled by linear diffusion and suggest that the monolayer does not completely block electron transfer, as these small molecules provide only a partial barrier. This decrease in both anodic and cothodic current is due to blocking behaviour of MP on gold modified electrode (Scheme 3).
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The TEM image (Figure 8 ) displays clearly aggregates of gold nanoparticles: colloidal gold has an average diameter of ca. 18 nm. On the addition of gold, aggregation of the gold takes place (this phenomenon was previously illustrated in Schemes 2 and 3).
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Determination of the antibacterial and antifungal activity of the 6-MP-colloidal gold complex Table 1 details the growth inhibition effected by drug-coated gold nanoparticles against both gramme positive and gramme negative organisms viz Micrococcus luteus, Staphylococcus aureus, Pseudomonas aeruginosa and E-Coli. It was observed that the coated colloid was most effective for gramme negative organisms and the levels of inhibition can be seen clearly in Figure 9 . 6-MP also shows a good antifungal activity against Aspergillus fumigatus and Aspergillus niger and these activity levels were found to be enhanced on the addition of colloidal gold (Table 2 and Figure 10 ). The colloidal gold solution alone does not show any appreciable antifungal and antibacterial activities.
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Table 2 Antifungal activity of 6-mercaptopurine (6-MP)
Although these preliminary studies demonstrate the effectiveness of the gold-drug complex, the precise mechanism by which it operates is not yet known and work continues to investigate this further. Some gold-drugs, namely aurothiomalate and aurothioglucose, have already been evaluated for activity against human immunodeficiency virus (HIV) for the treatment of AIDS 44, 45 and, in the same way, gold-drugs have been explored for their effectiveness as antifungal, antibacterial and anticancer agents. Gold-drugs are used more as last-line modes of treatment for severe cases of rheumatoid arthritis in favour of organic drugs. It gives more potent and reduced toxic side effects. These properties may be due to geomentry of the complex. 
Levels of Zone of inhibition Fungal Organisms
Pure 6-MP 6-MP-coated gold nanoparticles metabolite pathway and the release mechanism may be altered (favourably in some cases) by the presence of metal nanoparticles, to attain a greater efficiency and reduced side effects.
Conclusions
The binding of 6-mercaptopurine (6-MP) to colloidal gold via complexation through the thiol group was studied using different analytical techniques (e.g. U.V-Visible spectroscopy, cyclic voltammetry, transmission electron microscopy, fluorescence spectroscopy and IR spectroscopy). 
